Moreover, we found identical results in PPARγ or α deficient cell lines, demonstrating that the in vitro anti-cancer effects of GW6471 at these concentrations are likely off-target, although we cannot fully exclude differential GW6471 effects between tissues in vivo and the HAP1 cell line in vitro. Here, PPARG is linked to cancer.